Precipio, Inc. (PRPO) Stock Profile — Insider Trades & Financials

Smart-Money SignalNeutral · 47/100— Insiders are net sellers over 90 days (-$74K, 4 sales vs 3 buys)

Revenue$6.8M

Net Income$526.0K

EPS$-0.57

Gross Margin45.9%

Market Cap$46.8M

Price Performance

Historical data including institutional events

Company Profile

Ilan Danieli

CEO & Executive Director

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Employees: 60
Headquarters: New Haven, Connecticut, United States
Website: www.precipiodx.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...

Smart-Money SignalNeutral · 47/100— Insiders are net sellers over 90 days (-$74K, 4 sales vs 3 buys)

Revenue$6.8M

Net Income$526.0K

EPS$-0.57

Gross Margin45.9%

Market Cap$46.8M

Price Performance

Historical data including institutional events

Company Profile

Ilan Danieli

CEO & Executive Director

Employees: 60
Headquarters: New Haven, Connecticut, United States
Website: www.precipiodx.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...

Precipio, Inc.

Price Performance

Company Profile

The morning brief, before the bell.

Precipio, Inc.

Price Performance

Company Profile